Gain Therapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
Gain Therapeutics Capital Expenditures (CapEx) Growth & History (GANX)
Gain Therapeutics's capital expenditures (capex) was $22,493 for fiscal 2024.
View full Gain Therapeutics company overviewGain Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $22,493 | $7,135 | +46.46% |
| 2023 | 2023-12-31 | $15,358 | −$103,595 | −87.09% |
| 2022 | 2022-12-31 | $118,953 | $24,741 | +26.26% |
| 2021 | 2021-12-31 | $94,212 | $73,386 | +352.38% |
| 2020 | 2020-12-31 | $20,826 | — | — |
Gain Therapeutics quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $945 | $926 | +4873.68% |
| Q3 2024 | 2024-09-30 | $1 | −$649 | −99.85% |
| Q4 2023 | 2023-12-31 | $19 | −$9,379 | −99.80% |
| Q3 2023 | 2023-09-30 | $650 | −$56,529 | −98.86% |
| Q2 2023 | 2023-06-30 | $3,644 | −$40,907 | −91.82% |
| Q1 2023 | 2023-03-31 | $11,045 | $3,220 | +41.15% |
| Q4 2022 | 2022-12-31 | $9,398 | −$1,700 | −15.32% |
| Q3 2022 | 2022-09-30 | $57,179 | $25,056 | +78.00% |
| Q2 2022 | 2022-06-30 | $44,551 | $22,048 | +97.98% |
| Q1 2022 | 2022-03-31 | $7,825 | −$20,663 | −72.53% |
| Q4 2021 | 2021-12-31 | $11,098 | −$3,453 | −23.73% |
| Q3 2021 | 2021-09-30 | $32,123 | $30,707 | +2168.57% |
| Q2 2021 | 2021-06-30 | $22,503 | $22,465 | +59118.42% |
| Q1 2021 | 2021-03-31 | $28,488 | $23,591 | +481.74% |
| Q4 2020 | 2020-12-31 | $14,551 | — | — |
| Q3 2020 | 2020-09-30 | $1,416 | — | — |
| Q2 2020 | 2020-06-30 | $38 | — | — |
| Q1 2020 | 2020-03-31 | $4,897 | — | — |
Gain Therapeutics capital expenditures (capex) trends
Between the periods ended 2020-12-31 and 2024-12-31, Gain Therapeutics's capital expenditures (capex) increased from $20,826 to $22,493, a change of $1,667. The latest reported quarter, Q4 2024, shows $945.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gain Therapeutics source filings ↗